Pronađeno: 1-10 / 75 radova

Autori: Srdic-Rajic Tatjana V

>> Filter: Samo Article i Review

Naslov Computational Design, Synthesis, and In Vitro Evaluation of Novel Piperazine-Based HDAC Inhibitors as Potential Breast Cancer Therapeutics (Article; Early Access)
Autori Dizdarevic Sehija  Ruzic Dusan  Srdic-Rajic Tatjana V  Vujic Zorica B 
Info ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, (2026), vol. br. , str. -
Projekat Ministry of Science, Technological Development and Innovation, Republic of Serbia; University of Belgrade-Faculty of Pharmacy [451-03-136/2025-03/ 200161, 451-03-137/2025-03/ 200161]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati:
Naslov The Landscape of Ferroptosis-Related Gene Signatures as Molecular Stratification in Triple-Negative Breast Cancer (Article)
Autori Buta Marko N  Jeftic Nikola  Besu Irina V  Raketic Jovan M  Markovic Ivan Z  Djuric Ana A  Petrovic Nina M  Srdic-Rajic Tatjana V 
Info DIAGNOSTICS, (2026), vol. 16 br. 3, str. -
Projekat Ministry of Science, Technological Development and Innovation of the Republic of Serbia [451-03-136/2025-03/200043]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Identification of a Novel miR-122-5p/CDC25A Axis and Potential Therapeutic Targets for Chronic Myeloid Leukemia (Article)
Autori Ozer Yaman Serap  Petrovic Nina M  Yaman Selcuk  Akidan Osman  Cimbek Ahmet  Baycelebi Gulsah  Srdic-Rajic Tatjana V  Sami Ahmad  Misir Sema 
Info INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, (2025), vol. 26 br. 23, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Mononuclear isothiocyanate zinc complex with a pyridine-based thiazolyl-hydrazone ligand: Transformation into a 1D coordination polymer and anticancer activity against pancreatic Cancer cell lines (Article)
Autori Araskov Jovana B  Srdic-Rajic Tatjana V  Visnjevac Aleksandar  Blagojevic Vladimir A  Todorovic Tamara R  Filipovic Nenad R 
Info INORGANIC CHEMISTRY COMMUNICATIONS, (2025), vol. 182 br. , str. -
Projekat Ministry of Science, Technological Development and Innovation of Republic of Serbia [451-03-136/2025-03/200168, 451-03-137/2025-03/200116]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents (Article)
Autori Beljkas Milan  Ruzic Dusan  Djuric Ana A  Vuletic Ana M  Tchiehe Guilaine Nchugoua  Jallet Corinne  Cadet Daniel Veronique  Arimondo Paola B  Santibanez Juan Francisco  Srdic-Rajic Tatjana V  Nikolic Katarina M  Oljacic Slavica V  Petkovic Milos R 
Info FUTURE MEDICINAL CHEMISTRY, (2025), vol. 17 br. 4, str. 393-407
Projekat Ministry of Science, Technological Development and Innovation, Republic of Serbia; University of Belgrade-Faculty of Pharmacy [451- 03-65/2024-03/200161, 451-03-66/2024-03/200161]; Ministry of Science, Technological Development and Innovation, Republic of Serbia; University of Belgrade-Institute for Medical Research [451-03-66/2024-03/200015]; Ministry of Science, Technological Development and Innovation, Republic of Serbia; Institute for Oncology and Radiology of Serbia [451-03-66/2024-03/200043]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents (Article; Early Access)
Autori Beljkas Milan  Ruzic Dusan  Djuric Ana A  Vuletic Ana M  Tchiehe Guilaine Nchugoua  Jallet Corinne  Cadet Daniel Veronique  Arimondo Paola B  Santibanez Juan Francisco  Srdic-Rajic Tatjana V  Nikolic Katarina M  Oljacic Slavica V  Petkovic Milos R 
Info FUTURE MEDICINAL CHEMISTRY, (2025), vol. br. , str. -
Projekat Ministry of Science, Technological Development and Innovation, Republic of Serbia, through Grant Agreement with University of Belgrade-Faculty of Pharmacy [451- 03-65/2024-03/200161, 451-03-66/2024-03/200161]; Ministry of Science, Technological Development and Innovation, Republic of Serbia, through Grant Agreement with University of Belgrade-Institute for Medical Research [451-03-66/2024-03/200015]; Ministry of Science, Technological Development and Innovation, Republic of Serbia, through Grant Agreement with Institute for Oncology and Radiology of Serbia [451-03-66/2024-03/200043]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati:
Naslov Screening Algal and Cyanobacterial Extracts to Identify Potential Substitutes for Fetal Bovine Serum in Cellular Meat Cultivation (Article)
Autori Sibincic Nikolina  Krstic-Ristivojevic Maja V  Gligorijevic Nikola J  Velickovic Luka  Culafic Katarina  Jovanovic Zorana  Ivanov Aleksandar  Tubic Lora  Vialleix Carole  Michel Thibaut  Srdic-Rajic Tatjana V  Nikolic Milan R  Stojadinovic Marija M  Minic Simeon L 
Info FOODS, (2024), vol. 13 br. 23, str. -
Projekat Good Food Institute Field Catalyst Grant; Ministry of Science, Technological Development and Innovation, RS [451-03-66/2024-03/200168, 451-03-66/2024-03/200288, 451-03-66/2024-03/200026]; [ALG2MEAT]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Unveiling the 4-aminoquinoline derivatives as potent agents against pancreatic ductal adenocarcinoma (PDAC) cell lines (Article)
Autori Zivanovic Marija  Selakovic Milica  Pavic Aleksandar B  Selakovic Zivota  Solaja Bogdan A  Santibanez Juan Francisco  Srdic-Rajic Tatjana V 
Info CHEMICO-BIOLOGICAL INTERACTIONS, (2024), vol. 404 br. , str. -
Projekat Ministry of Science, Technological Development and Innovation of the Republic of Serbia [451-03-66/2024-03/200288, 451-03-66/2024-03/200168, 451-03-66/2024-03/200015, 451-03-66/2024-03/200043]; Serbian Academy of Sciences and Arts under the strategic projects program [01-2019-F65]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design (Article)
Autori Beljkas Milan  Petkovic Milos R  Vuletic Ana M  Djuric Ana A  Santibanez Juan Francisco  Srdic-Rajic Tatjana V  Nikolic Katarina M  Oljacic Slavica V 
Info PHARMACEUTICS, (2024), vol. 16 br. 10, str. -
Projekat Ministry of Science, Technological Development and Innovation, Republic of Serbia, through Grant Agreement with University of Belgrade (Faculty of Pharmacy); Ministry of Science, Technological Development and Innovation, Republic of Serbia [451-03-65/2024-03/200161, 451-03-66/2024-03/200161, 451-03-66/2024-03/200043, 451-03-66/2024-03/200015]; University of Belgrade (Faculty of Pharmacy)
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Quinoline-based thiazolyl-hydrazones target cancer cells through autophagy inhibition (Article)
Autori Curcic Vladimir  Olszewski Mateusz  Maciejewska Natalia  Visnjevac Aleksandar  Srdic-Rajic Tatjana V  Dobricic Vladimir D  Garcia-Sosa Alfonso T  Kokanov Sanja B  Araskov Jovana B  Silvestri Romano  Schuele Roland  Jung Manfred  Nikolic Milan R  Filipovic Nenad R 
Info ARCHIV DER PHARMAZIE, (2024), vol. 357 br. 2, str. -
Projekat Ministry of Science, Technological Development and Innovation of the Republic of Serbia [451-03-47/2023-01/200168, 451-03-47/2023-01/200161, 451-03-47/2023-01/200116]; AIRC IG 2020 [24703]; CIBBS Germany [EXC-2189, 390939984]; Estonian Research Council [PRG1509]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [SFB 992, 192904750]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati:
Ispis zapisa u formatu:TXT | BibTeX